From: Adolescent polycystic ovary syndrome according to the international evidence-based guideline
Target group | Strong recommendationsa | Conditional (weak) recommendations for the option (test or treatment) | Conditional (weak) recommendation for either the option or the comparison | Research-only recommendations | Clinical practice pointsb |
---|---|---|---|---|---|
Consumers | Most people in your situation would want the recommended course of action and only a small proportion would not | The majority of people in your situation would want the recommended course of action but some would not | There is considerable lack of clarity over whether the majority of people in your situation would want the recommended course of action or not | The test or intervention should only be considered by patients and clinicians within the setting of a research trial for which appropriate approvals and safety precautions have been established | Clinicians, patients and policy-makers are informed on the clinical implications relevant to implementation of recommendations |
Health professionals | Most patients should receive the recommended course of action | Recognise that different choices will be appropriate for different patients and that greater effort is needed with individuals to arrive at management decisions consistent with values and preferences Decision aids and shared decision-making are important here | Â | The test or intervention should only be considered by patients and clinicians within the setting of a research trial for which appropriate approvals and safety precautions have been established | Â |
Policy-makers | The recommendation can be adopted as policy in most situations | Policy-making needs to consider perspectives and involvement of diverse stakeholders | Policy decisions remain unclear | Policy-makers need to be aware of the need for evidence gaps and health professional and consumer-prioritised research gaps | Â |